AIBD Abstracts 2022

ABSTRACT

The proceedings contain 134 papers. The topics discussed include sarcopenia is associated with social determinants of health in patients with inflammatory bowel disease;predictor of thromboembolic complications in patients with ulcerative colitis and measures for their prevention;patient perspectives on the COVID-19 pandemic, its impact on inflammatory bowel disease treatment, and overall well-being one year later;characteristics and outcomes of patients with IBD admitted to high vs low safety net burden hospitals a nationwide analysis;serrated epithelial change to follow or not to follow?;how can we predict the development of antibodies to infliximab in Crohn's disease?;Crohn's disease what to do after anti-tumor necrosis factor-a therapy fails?;endoscopic scores as predictors of treatment failure in ulcerative colitis;management of hyperlipidemia induced by primary biliary cholangitis;development of shingles on tofacitinib despite completion of recombinant VZV vaccination series;impact of marijuana in ulcerative colitis with Nstemi hospitalizations insights from national inpatient sample 2016-2019;and association of quality of life with clinical remission, HEMR, and bowel urgency in patients with ulcerative colitis treated with Mirikizumab.